Boven E - Search Results

1

PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane.

Kruger DT, Opdam M, van der Noort V, Sanders J, Nieuwenhuis M, de Valk B, Beelen KJ, Linn SC, Boven E. Kruger DT, et al. Among authors: boven e. J Cancer Res Clin Oncol. 2020 Nov;146(11):3013-3023. doi: 10.1007/s00432-020-03291-x. Epub 2020 Jun 21. J Cancer Res Clin Oncol. 2020. PMID: 32566979 Free PMC article. Clinical Trial.

2

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.

de Wit R, Collette L, Sylvester R, de Mulder PH, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, van Oosterom AT, Boven E, Stoter G. de Wit R, et al. Among authors: boven e. Br J Cancer. 1998 Nov;78(10):1350-5. doi: 10.1038/bjc.1998.683. Br J Cancer. 1998. PMID: 9823978 Free PMC article.

3

Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity.

van Hattum AH, Hoogsteen IJ, Schlüper HM, Maliepaard M, Scheffer GL, Scheper RJ, Kohlhagen G, Pommier Y, Pinedo HM, Boven E. van Hattum AH, et al. Among authors: boven e. Br J Cancer. 2002 Sep 9;87(6):665-72. doi: 10.1038/sj.bjc.6600508. Br J Cancer. 2002. PMID: 12237778 Free PMC article.

4

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.

van der Veldt AA, Meijerink MR, van den Eertwegh AJ, Haanen JB, Boven E. van der Veldt AA, et al. Among authors: boven e. Br J Cancer. 2010 Mar 2;102(5):803-9. doi: 10.1038/sj.bjc.6605567. Epub 2010 Feb 9. Br J Cancer. 2010. PMID: 20145618 Free PMC article.

5

Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.

Kroep JR, Linn SC, Boven E, Bloemendal HJ, Baas J, Mandjes IA, van den Bosch J, Smit WM, de Graaf H, Schröder CP, Vermeulen GJ, Hop WC, Nortier JW. Kroep JR, et al. Among authors: boven e. Neth J Med. 2010 Sep;68(9):371-6. Neth J Med. 2010. PMID: 20876920 Free article.

6

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.

de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. de Ruiter MB, et al. Among authors: boven e. Hum Brain Mapp. 2012 Dec;33(12):2971-83. doi: 10.1002/hbm.21422. Epub 2011 Sep 23. Hum Brain Mapp. 2012. PMID: 22095746 Free PMC article.

7

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial.

Lam SW, de Groot SM, Honkoop AH, Jager A, ten Tije AJ, Bos MM, Linn SC, van den Bosch J, Kroep JR, Braun JJ, van Tinteren H, Boven E; Dutch Breast Cancer Research Group. Lam SW, et al. Among authors: boven e. Eur J Cancer. 2014 Dec;50(18):3077-88. doi: 10.1016/j.ejca.2014.10.008. Eur J Cancer. 2014. PMID: 25459393 Clinical Trial.

8

Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer.

Timmers L, Boons CC, Moes-Ten Hove J, Smit EF, van de Ven PM, Aerts JG, Swart EL, Boven E, Hugtenburg JG. Timmers L, et al. Among authors: boven e. J Cancer Res Clin Oncol. 2015 Aug;141(8):1481-91. doi: 10.1007/s00432-015-1935-0. Epub 2015 Mar 6. J Cancer Res Clin Oncol. 2015. PMID: 25743274 Free PMC article.

9

Angiogenesis- and Hypoxia-Associated Proteins as Early Indicators of the Outcome in Patients with Metastatic Breast Cancer Given First-Line Bevacizumab-Based Therapy.

Lam SW, Nota NM, Jager A, Bos MM, van den Bosch J, van der Velden AM, Portielje JE, Honkoop AH, van Tinteren H, Boven E; ATX Trial Team. Lam SW, et al. Among authors: boven e. Clin Cancer Res. 2016 Apr 1;22(7):1611-20. doi: 10.1158/1078-0432.CCR-15-1005. Epub 2016 Jan 28. Clin Cancer Res. 2016. PMID: 26823602

10

Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.

Lam SW, Frederiks CN, van der Straaten T, Honkoop AH, Guchelaar HJ, Boven E. Lam SW, et al. Among authors: boven e. Br J Cancer. 2016 Nov 22;115(11):1335-1342. doi: 10.1038/bjc.2016.326. Epub 2016 Oct 13. Br J Cancer. 2016. PMID: 27736846 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page